Comparative study of various biological markers in infection by HIV1.

Authors

  • J. E. Serra Infectious Diseases Clinic, Coimbra University Hospital.
  • V. Pombo Infectious Diseases Clinic, Coimbra University Hospital.
  • R. Côrte-Real Infectious Diseases Clinic, Coimbra University Hospital.
  • Saraiva Da Cunha Infectious Diseases Clinic, Coimbra University Hospital.
  • A. Meliço-Silvestre Infectious Diseases Clinic, Coimbra University Hospital.

DOI:

https://doi.org/10.20344/amp.3025

Abstract

A study was performed on 51 human immunodeficiency virus (HIV-1)-infected patients with a previous history of drug abuse. By the CDC staging system for HIV infection they were mainly in advanced stages of that infection, 67% were in IV-A and 8% in IV-CI. Patients were divided in two groups, one composed of 33 individuals who needed AZT therapy and the other of those who did not need that medication (18 patients). Between 3 and 18 months several parameters were assessed on 3 different occasions, according to standard techniques: red blood cells and platelet numeration, CD4 and CD8 cell counts, HIV antigen (p24 Ag), beta 2-microglobulin, high-density serum lipoproteins (HDL), and anticardiolipin antibodies (ACA). In the patients treated with AZT the first bioserologic evaluation was performed before starting this therapy. Finally it was observed that p24 AG and ACA were present in 21% of the patients, all of them in advanced stages of HIV infection and under AZT therapy. A significant correlation was only found between CD4 counts and beta 2-microglobulin (R = 0.34; P = 0.0001).

Downloads

Download data is not yet available.

Downloads

How to Cite

1.
Serra JE, Pombo V, Côrte-Real R, Da Cunha S, Meliço-Silvestre A. Comparative study of various biological markers in infection by HIV1. Acta Med Port [Internet]. 1994 Dec. 31 [cited 2024 Nov. 23];7:S9-S14. Available from: https://actamedicaportuguesa.com/revista/index.php/amp/article/view/3025

Issue

Vol. 7 (1994): Suplemento 1

Section

Arquivo Histórico

License

All the articles published in the AMP are open access and comply with the requirements of funding agencies or academic institutions. The AMP is governed by the terms of the Creative Commons ‘Attribution – Non-Commercial Use - (CC-BY-NC)’ license, regarding the use by third parties.

It is the author’s responsibility to obtain approval for the reproduction of figures, tables, etc. from other publications.

Upon acceptance of an article for publication, the authors will be asked to complete the ICMJE “Copyright Liability and Copyright Sharing Statement “(http://www.actamedicaportuguesa.com/info/AMP-NormasPublicacao.pdf) and the “Declaration of Potential Conflicts of Interest” (http:// www.icmje.org/conflicts-of-interest). An e-mail will be sent to the corresponding author to acknowledge receipt of the manuscript.

After publication, the authors are authorised to make their articles available in repositories of their institutions of origin, as long as they always mention where they were published and according to the Creative Commons license.

Crossref
Scopus
Google Scholar
Europe PMC